Stockreport

Profusa to Present US-Study Clinical Data at Leipzig Interventional Course (LINC) 2026

Profusa, Inc.  (PFSA) 
PDF Study conducted at US sites evaluates LumeeTM in peripheral artery disease (PAD) patients BERKELEY, Calif, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” [Read more]